PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
16084497-0	2005	DARPP-32 phosphorylation opposes the behavioral effects of nicotine.	Nicotine	59-67	protein phosphatase 1, regulatory inhibitor subunit 1B	Mus musculus	0-8	
16084497-2	2005	Because post-synaptic neurons within the striatum contain high levels of the dopamine- and cAMP-regulated phosphoprotein of 32 kDa (DARPP-32), we hypothesized that DARPP-32 may functionally contribute to the behavioral effects of nicotine.	Nicotine	230-238	protein phosphatase 1, regulatory inhibitor subunit 1B	Mus musculus	77-130	
16084497-2	2005	Because post-synaptic neurons within the striatum contain high levels of the dopamine- and cAMP-regulated phosphoprotein of 32 kDa (DARPP-32), we hypothesized that DARPP-32 may functionally contribute to the behavioral effects of nicotine.	Nicotine	230-238	protein phosphatase 1, regulatory inhibitor subunit 1B	Mus musculus	132-140	
16084497-2	2005	Because post-synaptic neurons within the striatum contain high levels of the dopamine- and cAMP-regulated phosphoprotein of 32 kDa (DARPP-32), we hypothesized that DARPP-32 may functionally contribute to the behavioral effects of nicotine.	Nicotine	230-238	protein phosphatase 1, regulatory inhibitor subunit 1B	Mus musculus	164-172	
16084497-9	2005	Systemic injections of nicotine resulted in increased striatal DARPP-32 phosphorylation at threonine34 and threonine75.	Nicotine	23-31	protein phosphatase 1, regulatory inhibitor subunit 1B	Mus musculus	63-71	
16084497-10	2005	CONCLUSIONS: DARPP-32 opposes the behavioral effects of nicotine possibly via concurrent phosphorylation at the two threonine sites.	Nicotine	56-64	protein phosphatase 1, regulatory inhibitor subunit 1B	Mus musculus	13-21